References
- Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med. 1991;324:1186–1194.
- Vincent DA Jr. Botulinum toxin in the management of laryngeal tics. J Voice. 2008;22:251–256.
- Ozcan C, Vayisoglu Y, Doğu O, et al. The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis. Am J Otolaryngol. 2006;27:314–318.
- Philouze P, Vertu D, Ceruse P. Bilateral gustatory sweating in the submandibular region after bilateral neck dissection successfully treated withbotulinum toxin. Br J Oral Maxillofac Surg. 2014;52:761–763.
- Rohrbach S, Olthoff A, Laskawi R, et al. Botulinum toxin type A induces apoptosis in nasal glands of guinea pigs. Ann Otol Rhinol Laryngol. 2001;110:1045–1050.
- Ellies M, Laskawi R, Götz W, et al. Immunohistochemical and morphometric investigations of the influence of botulinum toxin on the submandibular gland of the rat. Eur Arch Otorhinolaryngol. 1999;256:148–152.
- Ellies M, Laskawi R, Tormählen G, et al. The effect of local injection of Botulinum toxin A on the parotid gland of the rat: an immunohistochemical and morphometric study. J Oral Maxillofac Surg. 2000;58:1251–1256.
- Kim KS, Kim SS, Yoon JH, et al. The effect of botulinum toxin type A injection for intrinsic rhinitis. J Laryngol Otol. 1998;112:248–251.
- Shaari CM, Sanders I, Wu BL, et al. Rhinorrhea is decreased in dogs after nasal application of botulinum toxin. Otolaryngol Head Neck Surg. 1995;112:566–571.
- Handler SD, Magardino TM. Otitis media with effusion. In: Canalis RF, Lambert PR, editors. The ear. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 383–396.
- Institute of Laboratory Animal Research. Commission on Life Sciences. National Research Council. The guide for the care and use of laboratory animals. 7th ed. Washington (DC): National Academy of Sciences; 1996.
- Marchica CL, Pitaro J, Daniel SJ. Recurrent tube insertion for chronic otitis media with effusion in children over 6 years. Int J Pediatr Otorhinolaryngol. 2013;77:252–255.
- Flint PW, Haughey BH, Lund VJ, et al. Cummings Otolaryngology Head & Neck Surgery. Philadelphia: Mosby Elsevier; 2010.
- Tos M. Epidemiology and natural history of secretory otitis. Am J Otol. 1984;5:459–462.
- Rosenfeld RM, Culpepper L, Doyle KJ, et al. American Academy of Pediatrics Subcommittee on otitis media with effusion; American Academy of Family Physicians; American Academy of Otolaryngology – Head and Neck Surgery. Clinical Practice Guideline: Otitis Media with Effusion. Otolaryngol Head Neck Surg. 2004;130:S95–S118.
- Moore P, Naumann M. Handbook of Botulinum toxin treatment. 2nd ed. Hoboken (NJ): Blackwell Science Ltd.; 2003.
- Rohrbach S, Laskawi R. Botulinum-toxin inder Hals-Nasen-Ohrenheilkunde. Laryngo-Rhino-Otol. 2003;82:202–218.
- Rohrbach S, Laskawi R. Minimally invasive application of Botulinum toxin type A in nasal hypersecretion. ORL J Otorhinolaryngol Relat Spec. 2001;63:382–384.
- Chimona TS, Panayiotides JG, Papadakis CE, et al. Antihistamine effects on experimental middle ear inflammatory model. Eur Arch Otorhinolaryngol. 2008;265:899–905.
- Ünal M, Sevim S, Doğu O, et al. Effect of Botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial. Acta Otolaryngol. 2003;123:1060–1063.
- Zehlicke T, Punke C, Dressler D, et al. Intratympanic application of botulinum toxin: experiments in guinea pigs for excluding ototoxic effects. Eur Arch Otorhinolaryngol. 2008;265:167–170.